Building Authority in Colostrum Science
Challenge:
Medela was preparing to launch a colostrum collector product with a focus on NICU care and oral colostrum therapy for premature infants unable to feed by mouth. To position the product credibly, they needed authoritative educational content to build trust with clinicians and highlight the science behind colostrum use in fragile infants.
Rev’s Role:
Rev synthesized the latest colostrum research into a clear, evidence-based white paper and developed a companion webinar for healthcare professionals. Both pieces translated complex data into accessible, practice-oriented insights.
Outcome:
The white paper and webinar strengthened Medela’s authority in neonatal nutrition, supported clinician adoption of oral colostrum therapy, and helped pave the way for the successful introduction of the colostrum collector product.
Supporting Launch of Novel Human Milk Fortifier in the US
Challenge:
Launching a new human milk fortifier in the U.S. required credible scientific communication to build trust with clinicians and support adoption in a competitive space. The company needed clear, evidence-based materials to showcase the product’s benefits.
Rev’s Role:
Sarah supported the launch first as an employee, then as a consultant, contributing across multiple aspects of the evidence strategy. She authored clinical study reports, conducted secondary analyses, and developed scientific posters presented at major conferences. One poster proved so effective that the commercial team repurposed it as sales marketing material.
Outcome:
Rev’s contributions helped establish scientific credibility for the new fortifier and provided versatile assets that supported both clinical awareness, commercial adoption, and the product’s entry into the U.S. market.
Osteopontin in Infant Formula Regulation
Challenge:
A client working with Traverse Science needed an expert panel manuscript to clarify the regulatory pathway for a novel ingredient in the U.S. Without a clear scientific narrative, regulators and stakeholders struggle to align on next steps, delaying adoption and market entry.
Rev’s Role:
Rev collaborated with Traverse Science to co-author the expert panel manuscript, synthesizing complex data into a credible, regulator-facing narrative. The work required balancing scientific rigor with clarity to ensure the panel’s findings could withstand scrutiny and guide future decisions.
Outcome:
The manuscript provided a critical foundation for identifying the regulatory path in the U.S. By shaping the expert panel’s output into a clear and authoritative publication, Rev helped accelerate regulatory clarity.
Clients Include
